A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Comparison of Fixed-Dose Ranges of Atomoxetine Hydrochloride in Child Outpatients With Attention-Deficit/Hyperactivity Disorder
A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Comparison of Fixed-Dose Ranges of Atomoxetine Hydrochloride in Child Outpatients With Attention-Deficit/Hyperactivity Disorder
Atomoxetine versus placebo in Children with Attention-Deficit/Hyperactivity Disorder (ADHD)
Inclusion Criteria:
Exclusion Criteria:
Aichi, Japan
Chiba, Japan
Fukui, Japan
Fukuoka, Japan
Hokkaido, Japan
Hyōgo, Japan
Ibaraki, Japan
Ishikawa, Japan
Kanagawa, Japan
Kumamoto, Japan
Mie, Japan
Miyagi, Japan
Nagano, Japan
Nara, Japan
Okayama, Japan
Osaka, Japan
Saga, Japan
Shiga, Japan
Shizuoka, Japan
Tochigi, Japan
Tokushima, Japan
Tokyo, Japan
Toyama, Japan